Alpna Seth, Director of Keros Therapeutics KROS, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $28.1K. The latest trade was on 06/04.

AS

AS

Alpna Seth

Director

Company

Keros Therapeutics KROS

First filing

23/05/03

Trades

22 trades

Buys / sales

0 / 1

12-month net buying

−$28.1K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Keros TherapeuticsKROS	Open-market sale10b5-1 plan	06/04	06/05	2,625 sh	$10.72	$28,140	−21.2%